• You are here:  
  • Home
  • Publications

Publications

Α.1 Publications in international journals

  1. The effect of intrathecal fentanyl added to lidocaine for open prostatectomy surgery. European Journal of Anaesthesiology, Volume 22, Supplement 34, 2005.
  2. Brachytherapy for the treatment of prostate cancer. Cancer J., 13(5):302-312, September/October, 2007.
  3. Biopsy and implantation of the seminal vesicles. Brachytherapy. Vol. 11 (5): 334-340, September 2012.
  4. Treatment of high risk featured prostate cancer with a combination of hormonal therapy, I-125 brachytherapy boost and external beam irradiation. International Journal of Molecular Signature. Vol 4: 3-6, May-August 2015.
  5. Transrectal Ultrasound–guided Versus Transperineal Mapping Prostate Biopsy: Complication Comparison. Reviews in Urology. Vol. 20 (1), 2018. 
  6. The ratio of the number of biopsy specimens to prostate volume (biopsy density) > 1.5 improves the prostate cancer detection rate in men undergoing transperineal prostate biopsy. J Urol. 2019 Aug 202 (2): 264-271. doi 10.1097/JU0000000000000204. [Epub 2019 Jul 8].
  7. Transperineal mapping biopsy improves selection of brachytherapy boost for men with localized prostate cancer. Brachytherapy. 2020 -JanFeb;19(1):33-37/j.brachy. 2019.09.007. [Epub 2019 Nov.2].
  8. Long-term biochemical control and cause-specific survival in men with Gleason grade Group 4 and 5 prostate cancer treated with brachytherapy and external beam irradiation. Brachytherapy. 2020 May-Jun;19(3):275-281. doi: 10.1016/j.brachy.2020.01.008. Epub 2020 Mar 23.
  9. I-125 or Pd-103 for brachytherapy boost in men with high-risk prostate cancer: A comparison of survival and morbidity outcomes. Brachytherapy. 2020 Sep-Oct;19(5):567-573. doi: 10.1016/j.brachy.2020.06.001. Epub 2020 Aug 3.
  10. Transperineal prostate mapping biopsy identifies additional cancer locations in men considering focal therapy with PI- RADS 3-5 regions of interest. BJUI Compass. 2021;1–7.   DOI: 10.1002/bco2.111. Epub 2021 Aug. 21. 
  11. Comparison of AUA and phoenix definitions of biochemical failure following permanent brachytherapy for prostate cancer. Brachytherapy. 2022 Nov-Dec;21(6):833-838.
  12. A unified strategy to focal brachytherapy incorporating transperineal biopsy, image fusion, and real-time implantation with and without rectal spacer simulated in prostate phantoms. J Contemp Brachytherapy. 2024 Apr;16(2):139-149.
  13. Method to determine the nadir PSA following partial gland ablation. BJUI Compass, 2025. PMID: 39958259. BJUI Compass. 2025 Feb 14;6(2):e496. doi: 10.1002/bco2.496. eCollection 2025 Feb.

Α.2 Publications in Greek journals

  1. Management of major bleeding in operating female urethral prolapse. Hellenic Urology, volume 14, issue 3. July-September 2002.
  2. Leiomyoma of female urethra. Hellenic Urology, volume 14, issue 3. July-September 2002.
  3. Evaluation of Bosniak classification for differential diagnosis of renal cystic masses. Hellenic Urology, volume 14, issue 3. July-September 2002.
  4. Brachytherapy for prostate cancer – The latest news. Contemporary Urology. April-June 2012/32.
  5. Brachytherapy for prostate adenocarcinoma. Iatrika Analekta. Volume C’, Issue 16. October-December 2012, p. 754-758.
  6. Comparison of the results Urology of the results and complications for transrectal ultrasound guided versus transperineal mapping biopsy of the prostate. Hellenic Urology. Vol. 31, No 2 (2019). P. 28-35.

B. Book chapters

  1. «Prostate Specific Antigen.» Brachytherapy of Localized Prostate Carcinoma. ISBN 978-960-394-547-5. 2009.
  2. «Dosimetry Protocol. Imlantation-Radiation Precautions.» Brachytherapy of Localized Prostate Carcinoma. ISBN 978-960-394-547-5. 2009.
  3. «Combination of Brachytherapy-Hormonal Therapy» Brachytherapy of Localized Prostate Carcinoma. ISBN 978-960-394-547-5. 2009.
  4. Transperineal Biopsy Technique”. The Prostate Cancer Dilemma. Springer International Publishing AG, Switzerland, 2016. ISBN 978-3-319-21484-9.
  5. “Elastography: Can it Improve Prostate Biopsy Results?” The Prostate Cancer Dilemma. Springer International Publishing AG, Switzerland, 2016. ISBN 978-3-319-21484-9.                                       

C.1 Abstracts in international congresses 

  1. Elimination of t-PSA and f-PSA after radical retropubic prostatectomy. XIXth EAU Congress. 24-27 March 2004. Vienna, Austria.
  2. Treatment of locally advanced prostate cancer with combination of hormonal therapy, I-125 brachytherapy boost and conformal external beam irradiation: preliminary results. XXth EAU Congress. 16-19 March 2005. CNR, Istanbul, Turkey.
  3. The effect of intrathecal fentanyl added to lidocaine for open prostatectomy surgery. Annual Meeting of the European Society of Anaesthesiology. 28-31 May 2005. Vienna, Austria.
  4. Dose response study of Pd-103 prostate seed implantation. ASTRO 49th Annual Meeting. October 28-November 1, 2007. Los Angeles Convention Center. Los Angeles, California, USA.
  5. Impact of prostate volume as a predictor of urinary incontinence following radioactive seed implantation for prostate cancer. ASTRO 49th Annual Meeting. October 28-November 1, 2007. Los Angeles Convention Center. Los Angeles, California, USA.
  6. Treatment of T3b prostate cancer with a combination of hormonal therapy, permanent brachytherapy and external beam irradiation. 2008 World Congress of Brachytherapy. Joint Brachytherapy Meeting: ABS, GEC/ESTRO, ALATRO, CBG-CARO, JASTRO, ABG and AROI-IBS. May 4-6, 2008. Marriot Copley Place. Boston, MA, USA.
  7. Defining the risk of developing grade 2 proctitis following combined modality therapy using a rectal dose-volume histogram analysis and biologic equivalent dose. ASTRO 50th Annual Meeting. September 21-25, 2008. Boston Convention and Exhibition Center. Boston, MA, USA.
  8. Transperineal template-guided mapping biopsy for detection of prostate cancer as an initial approach. 10th Congress of the European Federation of Internal Medicine. October 5-8 2011, Hilton Hotel, Athens, Greece.
  9. Outcomes of transperineal template-guided mapping prostate biopsy after negative transrectal ultrasound guided biopsy. 3rd Congress of the Mediterranean Multidisciplinary Oncology Forum. October 24-26, 2013. Divani Caravel Hotel. Athens, Greece.
  10.  Treatment of locally advanced (high risk) prostate cancer (PCa) by a combination of hormonal therapy, brachytherapy and external beam irradiation. 3rd Congress of the Mediterranean Multidisciplinary Oncology Forum. October 24-26, 2013. Divani Caravel Hotel. Athens, Greece.
  11. Transperineal saturation prostate biopsy (TSPB): Factors predicting oncologic and quality of life outcomes. 19th Annual Scottsdale Prostate Cancer Symposium 2014. February 27-March 2, 2014. A JW Marriot Camelback Inn Resort and Spa. Scottsdale, Arizona, USA.
  12. Testosterone recovery (TR) and PSA increase following neoadjuvant hormone therapy (NHT) with prostate irradiation. 19th Annual Scottsdale Prostate Cancer Symposium 2014. February 27-March 2, 2014. A JW Marriot Camelback Inn Resort and Spa. Scottsdale, Arizona, USA.
  13. Technique of 3D mapping biopsy. Results and morbidity. 20th Annual Scottsdale Prostate Cancer Symposium 2015. March 5-8, 2015. JW Marriot Camelback Inn Resort and Spa. Scottsdale, Arizona, USA. 
  14. Trimodality therapy in high risk disease. 20th Annual Scottsdale Prostate Cancer Symposium 2015. March 5-8, 2015. JW Marriot Camelback Inn Resort and Spa. Scottsdale, Arizona, USA. 
  15. Results of transperineal mapping biopsy of the prostate. 110thAUA 2015 Annual Meeting. May 15-19, 2015. New Orleans Morial Convention Center. New Orleans, LA, USΑ.
  16. Transperineal prostate biopsy with new mapping software. 110thAUA 2015 Annual Meeting. May 15-19, 2015. New Orleans Morial Convention Center. New Orleans, LA, USΑ.
  17. Treatment of High Risk Prostate Cancer with a Trimodality Approach consisting of Hormonal Therapy, I-125 Brachytherapy Seed Implant and External Beam Irradiation. Results and Associated Morbidity. CancerDiagnosis & Therapy Congress. September 3-4, 2015. London, UK.
  18. Development of a 3D prostate mapping system. 91stAnnual Congress of Western Section of AUA. October 25-29, 2015. Renaissance, Esmeralda, USA.
  19. Results of transperineal prostate biopsy using 3D mapping software. 91stAnnual Congress of Western Section of AUA. October 25-29, 2015. Renaissance, Esmeralda, USA.
  20. Prostate brachytherapy for the treatment of prostate cancer. EUROSON 2015, 27th ESUMB Congress, 11th Congress HSUMB, November 6-8, Hilton Hotel, Athens, Greece.
  21. Complications associated with transrectal and transperineal prostate mapping biopsy.111thAUA 2016 Annual Meeting. May 6-10, 2016. San Diego Convention Center. San Diego, CA, USΑ.
  22. Transperineal mapping biopsy correctly identifies candidates for radical prostatectomy. 111thAUA 2016 Annual Meeting. May 6-10, 2016. San Diego Convention Center. San Diego, CA, USΑ.
  23. Identification of the index lesion and contralateral significant cancer in men undergoing transperineal mapping biopsy. EAU 19 Congress, March 15-19, 2019. Fira Grand Via, Barcelona, Spain. 
  24. Comparison of the oncologic outcomes of men with high risk prostate cancer treated with either I-125 or Pd-103 brachytherapy. EAU 19 Congress, March 15-19, 2019. Fira Grand Via, Barcelona, Spain.
  25. Comparison of the morbidity in men with intermediate and high-risk prostate cancer treatedwith either I-125 or Pd-103 brachytherapy combined with external beam irradiation. EAU 19 Congress, March 15-19, 2019. Fira Grand Via, Barcelona, Spain.
  26. The ratio of the number of biopsy specimens to prostate volume (biopsy density) > 1.5 improves the detection of clinically significant cancers in men undergoing transperineal biopsy of the prostate. ABS Annual Meeting. June 13-15, 2019, Miami Intercontinental, Miami, Florida, USA. 
  27. Transperineal prostate mapping biopsy improves treatment selection in men receiving brachytherapy. ABS Annual Meeting. June 13-15, 2019, Miami Intercontinental, Miami, Florida, USA.
  28. Outcomes of men with Gleason grade group 4 and 5 disease treated with prostate brachytherapy. ABS Annual Meeting. June 13-15, 2019, Miami Intercontinental, Miami, Florida, USA.
  29. Do either I-125 or Pd-103 brachytherapy provide a superior boost when combined with external beam irradiation in men with high risk prostate cancer? ABS Annual Meeting. June 13-15, 2019, Miami Intercontinental, Miami, Florida, USA.
  30. The number of biopsy sites (biopsy density) in men undergoing transperineal prostate mapping biopsy (TPMB) improves the cancer detection rate. Annual German Urology Meeting - DGU Congress 2019, September 18 - 21, 2019. Hamburg Messe, Germany.
  31. Comparison of the morbidity in men with high-risk prostate cancer treated with either I-125 or Pd-103 brachytherapy combined with external beam irradiation. Annual German Urology Meeting - DGU Congress 2019, September 18 - 21, 2019. Hamburg Messe, Germany.
  32. Comparison of the oncologic outcomes of men with high risk prostate cancer treated with either I-125 orPd-103 brachytherapy. Annual German Urology Meeting - DGU Congress 2019, September 18 - 21, 2019. Hamburg Messe, Germany.
  33. Performance of prostatic specific antigen density (PSAD) predicting clinically significant prostate cancer (csPCa) in biopsy naive men, with a prior negative TRUS biopsy, or low-grade cancer. 116thAUA 2021 Annual Meeting. September 10-13, 2021. Las Vegas, Nevada, USΑ.
  34. The Future Of Hands-on Education: Remote Training Platform Utilizing Augmented Reality. 9thMeeting of the EAU Section of Urological Imaging. November 25, 202. Athens Megaron Conference Center, Greece. 
  35. Transperineal prostate mapping biopsy improves the selection of implant alone or combination therapy in intermediate risk patients. 25th Annual Scottsdale Prostate Cancer Symposium 2021. December 9-11, 2021. Westin Kierland Resort and Spa. Scottsdale, Arizona, USA.
  36. Comprehensive Analysis of Morbidity Following Transperineal Prostate Biopsy. 117thAUA 2022 Annual Meeting. May 13-16, 2022. Ernest N. Morial Convention Center. New Orleans, USA. AUA 2022
  37. Partial prostate gland ablation: lesion location using transperineal mapping biopsy (TPMB). 117thAUA 2022 Annual Meeting. May 13-16, 2022. Ernest N. Morial Convention Center. New Orleans, USA.

C.2 Abstracts in Greek Congresses

1. Hormonal fluctuations in patients with prostate cancer after radical prostatectomy. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.

2. Management of stress urinary incontinence with tension free vaginal tape (TVT). 15/05/02. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.

3. Prognostic importance of DNA nucleus ploidy in surgically removed prostate tumor specimens. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.

4. Usefulness of transitional zone biopsy in detecting prostate adenocarcinoma. 16th Greek Urological Congress. September 25-29, 2002. 5. Kalamata, Greece.

5. Anuria from echinococcous cyst in patient with one kidney. 16th Greek Urological Congress. September 25-29, 2002. Kalamata, Greece.

Brachytherapy on confined prostate carcinoma. Our five years experience. 1st International Greek Biotechnology Forum. June 10-12, 2004. National Research Institute. Athens, Greece.

6. Prostate brachytherapy at Hygeia hospital. Radiation Oncology: Redefining the future… today!, May 16-17, 2009. Hilton Hotel, Athens, Greece.

7. Prostate brachytherapy at Hygeia Hospital. Results with a median follow up of 4 years. “1st Panhellenic Congress of oncologic imaging” October 23-25, 2009. Megaro International Congress Center, Athens, Greece.

8. 3-D Transperineal prostate biopsy (mapping biopsy). Our initial Experience at Hygeia Hospital. «1st Panhellenic Congress of oncologic imaging» October 23-25, 2009. Megaro International Congress Center, Athens, Greece.

8. 3-D Transperineal prostate biopsy (mapping biopsy). Our Experience at Hygeia Hospital. 20th Panhellenic Urological Congress, October 24-27, 2010. Grand Resort Hotel, Limassol, Cyprus.

9. Interstitial radioactive I-125 seeds implantation of prostate with Real-Time technique. Results with a median follow up of 4 years. 20th Panhellenic Urological Congress, October 24-27, 2010. Grand Resort Hotel, Limassol, Cyprus.

10. Transperineal template-guided mapping biopsy for detection of prostate cancer as an initial approach. 17th Panhellenic Congress of Internal Medicine, October 5-8, 2011. Hilton Hotel, Athens, Greece.

11. Transperineal template-guided prostate biopsy for detection of transitional zone involvement in prostate cancer . “2nd Panhellenic Congress of oncologic imaging”, December 9-11, 2011. Royal Olympic Hotel, Athens, Greece.

12. Combination of hormonal therapy, brachytherapy and supplemental external beam irradiation in patients with gleason score 7-10 prostate cancer. “2nd Panhellenic Congress of oncologic imaging”, December 9-11, 2011. Royal Olympic Hotel, Athens, Greece.

13. Treatment of Gleason 8-10 prostate cancer with a triple offensive combination regimen. 21th Panhellenic Congress of Urology. October 11-14, 2012. Hilton Hotel, Athens, Greece.

14. Morbidity of transperineal prostate biopsy in diagnosis and staging of prostate cancer. 21th Panhellenic Congress of Urology. October 11-14, 2012. Hilton Hotel, Athens, Greece.

15. Prostate cancer. Transperineal prostate biopsy. Blood-free treatment. Brachytherapy. AKOS-Prolipsis Erga. October 21, 2012. Holy Metamorfoseos Monastery. Nafpaktos, Greece.

16. «AKOS-Blood-less wins». Participation in round-table: «Prostate Cancer» November 11, 2012. Athinais, Polyhoros Politismou. Athens, Greece.

 

17. Comparison of compression elastography findings and pathology results through transperineal template guided prostate biopsy. 3nd Panhellenic Oncological-Imaging Congress. December 13-15, 2013. Mitera Hospital, Congress Center “N. Louros”, Maroussi, Athens, Greece. (HONORED-GOLD MEDAL)

 

18. Disease free survival and quality of life of patients with low risk prostate cancer treated with high implant dose LDR prostate brachytherapy. 3nd Panhellenic Oncological-Imaging Congress. December 13-15, 2013. Mitera Hospital, Congress Center “N. Louros”, Maroussi, Athens, Greece.

 

19. Testosterone recovery and associated temporary PSA increase after combination of hormonal therapy and radiotherapy in prostate cancer treatment. 22nd Panhellenic Congress of Urology. October 16-19, 2014. Creta Maris Hotel. Heraklio, Crete, Greece.

 

20. Transperineal template guided prostate biopsy: Factors affecting results and quality of life. 22nd Panhellenic Congress of Urology. October 16-19, 2014. Creta Maris Hotel. Heraklio, Crete, Greece.

 

21. Real Time technique of prostate brachytherapy in prostate cancer patients with gland volume  > 50cm3. 22ndPanhellenic Congress of Urology. October 16-19, 2014. Creta Maris Hotel. Heraklio, Crete, Greece.

 

22. Brachytherapy and External Irradiation. AKOS ‘‘Sacred Pelvis and Cancer’’, January 31, 2015. Divani Caravel Hotel, Athens, Greece.

 

23. Complications associated with transrectal and transperineal prostate mapping biopsy. 23nd Panhellenic Congress of Urology. October 20-23, 2016. Rodos Palace Hotel, Greece.

 

24. Transperineal prostate mapping biopsy correctly identifies candidates for radical prostatectomy. 23nd. Panhellenic Congress of Urology. October 20-23, 2016. Rodos Palace Hotel, Greece.

 

25. A better biopsy. Implications for focal therapy. 23nd Panhellenic Congress of Urology. October 20-23, 2016. Rodos Palace Hotel, Greece.

 

26. Transperineal 3D prostate biopsy at Hygeia Hospital (2008-2016). 23nd Panhellenic Congress of Urology. October 20-23, 2016. Rodos Palace Hotel, Greece.

 

27. Treatment results of high risk patients with a combination of hormonal therapy, brachytherapy and conformal external beam irradiation. 23nd Panhellenic Congress of Urology. October 20-23, 2016. Rodos Palace Hotel, Greece.

 

28. Imaging and staging biopsy of prostate cancer -3D Transperineal biopsy. “New dimension in management of cancer” AKOS -Cancer, treatment of body and soul February 3-4, 201 Crowne Plaza Hotel, Athens.

 

29. Prostate brachytherapy for prostate cancer. Scientific Meeting “Prostate cancer, our common enemy”, March 18, 2017. Paleo Mihanourgio, Lavrio Attiki. 

 

30. Pathological mapping of prostate gland. New horizons in treatment of localized disease. “3D biopsy”. AKOS – “Controversies in Oncology” – Cancer, treatment of Body and Soul”, February 2 & 3, 2018. Crowne Plaza Hotel, Athens.